5 Key Takeaways of Psychedelic-Assisted Therapy Training

Take an expedition into the heart of psychedelic-assisted therapy with Numinus’ Fundamentals of Psychedelic-Assisted Therapy course. In this 8-week virtual training, you will uncover a wealth of insights and skills that transcend conventional forms of mental health treatment options. 

The Course Unveiled

At the core of this journey lies the opportunity to learn from seasoned Numinus practitioners. Our team’s real-life experiences in integrative and transformative mental wellness will be your guideposts, illuminating genuine scenarios and situations that you’ll likely uncover as you build your career as a psychedelic therapist or guide.

Key Learnings

Holistic Model of Care

Psychedelic Therapy Arc

Inner Healing Intelligence

Psychological Flexibility in Practice

Navigating Altered States

Professional Resilience

As you emerge from Fundamentals of Psychedelic-Assisted Therapy, you not only carry a certificate of completion but a newfound community. This course extends beyond education; it's an opportunity to build connections with like-minded individuals who share your commitment to reshaping the future of mental health. Listen to Fundamentals alum Reilly Capps reflect on his experience with our training.

Join Numinus in contributing to the evolution of mental healthcare. Enroll in the transformative journey of Fundamentals of Psychedelic-Assisted Therapy and empower yourself to make a lasting impact on the well-being of those you serve.

Sign up for Fundamentals today! 

Fundamentals of Psychedelic-Assisted Therapy Training: Claudia's Experience

The below testimonial was written by one of our Fundamentals of Psychedelic-Assisted Therapy learners, Claudia Bastien. Claudia is a breath work and cold exposure facilitator who applied her studies in this course to holistic healing - an indirect yet adjacent and highly applicable field of work for this certification. 

At the end of 2023, I completed my Fundamentals of Psychedelic Assisted Therapy (PAT) Training with Numinus.

To be honest, when I signed up for this training, my primary motivator was not to hold plant medicine sessions.

To be honest it still isn’t my motivator.

No, I choose to take on this training to expand my tool box in assisting and supporting individuals through altered states of consciousness that aren’t achieved by ingesting a psychedelic substance… but instead, altered states of consciousness that one can tap into via one’s own breath and body… through breath work and cold exposure therapy.

After 3 years of guiding cold exposure and utilizing breath to help individuals to regulate their own nervous systems… I’ve seen first hand the sheer power that breath and cold water can have on an individual. After 7yrs of my own practice, I know first hand the impacts that these modalities have on the psyche. I have felt the psychedelic-like effects that wash over the body after a particularly good breath work or cold exposure session. The out of body feeling - the floating - the melting - the humming. The interoception of feeling one’s heartbeat, the circulation of the blood around the body - the lungs collapsing and expanding. The tingles. The sounds in the ears, the deafening silence, the ringing.

In my experience breath work & cold exposure therapy can lead to impactful psychedelic-like effects. Although short-lived in experience - the “downloads” one receives can be concentrated and intense.

It is all this that lead me to training with Numinus.

Here is what impressed me most during my 8-week long intensive.

Whether you are a licensed or unlicensed practitioner, I think anyone who works with individuals who enter altered states of consciousness could benefit on the knowledge expansion that you receive by taking the Fundamentals in PAT training.

It was a challenging 2 months, but I couldn’t recommend this training enough… and that’s my honest, unsponsored opinion.

Westernized Education Framework.

The training is set up within a westernized education framework. As someone who dedicated 10+ years of my career to working with postsecondary education - I highly value an education that makes me feel like I'm attending a recognized university.

Professional. Responsible. Accountable. 

With 2.5 hour pre-work modules, 3 hour live interactive sessions with Numinus practitioners (registered and practicing counselors & physicians), small group learning sessions, and interactive exercises with the class every week… for something as serious as guiding others through medicine journeys, I find peace in knowing that this course is challenging and demanding. After losing a loved one to an intricate mental health journey that was spurred by an intense plant medicine session, I was glad to see that Numinus takes the weight of training seriously.

Comprehensive Curriculum.

The volume of information divulged module to module was intense. I still can’t believe how much was covered in essentially 50 hours over 8 weeks. I learned new and innovative ways to make adjustments to the way in which individuals can prepare for their session, language that can be helpful in communicating boundaries and expectations, and best practices around supporting individuals through their unique integration journeys. Much to my delight, we talked at length about the Nervous System and how altered states of consciousness can benefit the regulation and reset of the NS. We covered medicine sessions, different medicines, case studies, practitioner self care, and so much more.

Click to learn more about our Fundamentals Course and the entire Psychedelic-Assisted Therapy Certification Pathway.

FDA Acceptance and Priority Review: Lykos Therapeutics' MDMA-Assisted Therapy Breakthrough for PTSD

In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted priority review to Lykos Therapeutics' (formerly MAPS PBC) MDMA-assisted therapy for individuals with post-traumatic stress disorder (PTSD). This development not only marks a significant leap in mental health treatment but also holds profound implications for companies like Numinus in the field of psychedelic-assisted therapy. 

Understanding the FDA Priority Review

The FDA's priority review is a special designation reserved for drugs that promise substantial improvements in safety or effectiveness compared to standard treatments. In the case of MDMA-assisted therapy, this acknowledgment underscores the urgent need for innovative approaches to address the complexities of PTSD. MDMA-assisted therapy was only submitted as a new drug application to the FDA by non-profit Multidisciplinary Association of Psychedelic Studies (MAPS) in December 2023.

A Glimpse into MDMA-Assisted Therapy

MDMA-assisted therapy, an important and promising venture in mental health treatment, involves the use of midomafetamine capsules (MDMA) in combination with intentional therapy before, during, and after each medicine session. Based on the data from two published Phase 3 studies completed by MAPS and numerous other trials, MDMA-assisted therapy is a real breakthrough in the treatment of PTSD. 

What This Means for Numinus and the Psychedelic Therapy Landscape

Validation of Psychedelic Therapies

The FDA's early acknowledgment of the potential benefits of MDMA-assisted therapy provides a significant boost to the legitimacy of psychedelic therapies. This is good news that we anticipate will pave the way for broader acceptance and integration of these treatments into mainstream mental healthcare.

Expanding Treatment Options

If (and when) approved, this therapy would represent a monumental shift in the available treatment options for PTSD. Companies like Numinus, already at the forefront of psychedelic therapy, may see expanded opportunities to offer innovative solutions for people suffering from post traumatic stress disorder. 

PTSD, a grave mental health condition stemming from traumatic events, grips approximately 13 million Americans each year. Military personnel have a greater prevalence of PTSD than the general population, however, it may not be as widely known that that the largest cause of PTSD is non-combat-related trauma (e.g., sexual violence, unexpected death of a loved one, life-threatening traumatic event or interpersonal violence). Women and marginalized groups bear a disproportionate burden, underscoring the urgency for inclusive and targeted treatment. With this treatment available, Numinus will be able to provide this option for relief that these people need and deserve across our network of clinics.

Heightened Focus on Safety and Efficacy

The FDA's priority review signals a keen focus on ensuring the safety and efficacy of psychedelic treatments. This emphasis aligns with Numinus's commitment to providing evidence-based and responsible psychedelic-assisted therapy.

Psychedelic-Assisted Therapy Training 

With increasing public awareness and acceptance of psychedelic medicine, our training program is pivotal in preparing professionals to meet the demand for responsible and safe MDMA-assisted therapy. As the therapeutic landscape expands, Numinus-trained and certified practitioners will be ready to integrate psychedelic assisted protocols into their practice. This transformative period presents opportunities for collaboration and cements the role of our training programs in moving this type of treatment forward. Learn more about our certification pathway here.

Looking Ahead

We are deeply invested in the transformative power of psychedelics and are thrilled to learn about the FDAs priority review of MDMA-assisted therapy. Our team wholeheartedly believes this development can and will change lives.